← Leaderboards
Keith Gregory Heinzerling
University Of California Los Angeles
$7,843,058
Attributed
$7,843,058
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2008–18$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$7,843,058 · 4
By mechanism
R01$6,710,275 · 2
K23$848,340 · 1
R21$284,443 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Tyrone D Cannon$27,059,387
- Thomas Frederick Newton$18,826,829
- Cherie Savine Blair$1,011,960
- Yih-Ing Hser$23,860,625
- William M Burdon$3,334,219
Others in their field
Top investigators on “Placebos”
- Beth Baseler · Leidos Biomedical Research, Inc.$141,816,521
- Randall J Bateman · Washington University$134,290,222
- Elizabeth A Thom · George Washington University$115,751,620
- Eric Martin McDade · Washington University$96,859,497
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$93,253,804
- Georgia D Tomaras · Fred Hutchinson Cancer Center$93,253,804
Research focus
PlacebosPharmaceutical PreparationsParticipantClinical TrialsRandomizedResponseMethamphetamineFundingContingency ManagementBupropionPharmacotherapyEffective TherapyMethamphetamine DependenceSubgroupGenesFrequencies (Time Pattern)Cognitive TherapyPublic Health Medicine (Field)SafetyGenetic PolymorphismDouble-Blind MethodAdverse EventRandomized TrialMedication Compliance
Grant awards (16)
Phase 1 safety-interaction study of pomaglumetad methionil for methamphetamine use disorder$1,235,461
R01 · FY2018 · DA · contact PI
Phase 1 safety-interaction study of pomaglumetad methionil for methamphetamine use disorder$1,145,783
R01 · FY2017 · DA · contact PI
Randomized Trial of Ibudilast for Methamphetamine Dependence$588,820
R01 · FY2017 · DA · contact PI
Phase 1 safety-interaction study of pomaglumetad methionil for methamphetamine use disorder$1,024,387
R01 · FY2016 · DA · contact PI
Randomized Trial of Ibudilast for Methamphetamine Dependence$614,002
R01 · FY2016 · DA · contact PI
Randomized Trial of Ibudilast for Methamphetamine Dependence$632,105
R01 · FY2015 · DA · contact PI
Administrative Supplement to Randomized Trial of Ibudilast for Methamphetamine Dependence$123,775
R01 · FY2015 · DA · contact PI
Randomized Trial of Ibudilast for Methamphetamine Dependence$663,956
R01 · FY2014 · DA · contact PI
Randomized Trial of Ibudilast for Methamphetamine Dependence$681,986
R01 · FY2012 · DA · contact PI
Pharmacogenomics and Medication Development for Methamphetamine Dependence$169,668
K23 · FY2012 · DA · contact PI
Pharmacogenomics and Medication Development for Methamphetamine Dependence$169,668
K23 · FY2011 · DA · contact PI
Pharmacogenomics and Medication Development for Methamphetamine Dependence$169,668
K23 · FY2010 · DA · contact PI
Pilot Trial of Bupropion versus Placebo for Methamphetamine Abuse in Adolescents$122,473
R21 · FY2010 · DA · contact PI
Pharmacogenomics and Medication Development for Methamphetamine Dependence$169,668
K23 · FY2009 · DA · contact PI
Pilot Trial of Bupropion versus Placebo for Methamphetamine Abuse in Adolescents$161,970
R21 · FY2009 · DA · contact PI
Pharmacogenomics and Medication Development for Methamphetamine Dependence$169,668
K23 · FY2008 · DA · contact PI